Product Name | CPI-0610 |
---|---|
CAS | 1380087-89-7 |
Formula | C20H16ClN3O2 |
MW | 365.81 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
5 mg | In-stock | $850.00 | Visible after login | |
10 mg | In-stock | $1360.00 | Visible after login |
Product Name | CPI-0610 |
---|---|
CAS | 1380087-89-7 |
Formula | C20H16ClN3O2 |
MW | 365.81 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Pelabresib (CPI-0610) is a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor with an IC50 of 39 nM for BRD4-BD1 in TR-FRET assay and currently undergoing human clinical trials for hematological malignancies. CPI-0610 inhibits the expression of Nuclear receptor binding SET domain protein 3 (NSD3) target genes.